Efficacy and Safety of ATG-Fresenius as an Induction Agent in Living-Donor Kidney Transplantation
Articles > Article · 2017
Authors: Mümtaz YILMAZ, Taylan Özgür SEZER, ESİN GÜNAY, I. SOLAK, Aygül ÇELTİK, C. HOSCOSKUN, Hüseyin TÖZ
Transplantation Proceedings, Journal Indexed in SCI Expanded, International, WoS, 2017, vol 49, pp 481-485
DOI: 10.1016/j.transproceed.2017.02.005
Summary
Background. Induction therapy is mostly recommended for deceased-donor transplantation, whereas it has some controversies in live-donor transplantation. In this study, we described the outcomes of live-donor renal transplant recipients who received ATG-Fresenius (ATG-F) induction.